Herbert Schuster

2.8k total citations
59 papers, 2.0k citations indexed

About

Herbert Schuster is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Herbert Schuster has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 21 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Molecular Biology. Recurrent topics in Herbert Schuster's work include Lipoproteins and Cardiovascular Health (18 papers), Hormonal Regulation and Hypertension (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). Herbert Schuster is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Hormonal Regulation and Hypertension (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). Herbert Schuster collaborates with scholars based in Germany, United States and United Kingdom. Herbert Schuster's co-authors include Friedrich C. Luft, Robert F. Spetzler, Richard A. Roski, Hans Knoblauch, Andreas Busjahn, Hans‐Dieter Faulhaber, Sylvia Bähring, Thomas F. Wienker, Magda Rosenthal and Heike Baron and has published in prestigious journals such as Circulation, Nature Genetics and Nature Biotechnology.

In The Last Decade

Herbert Schuster

59 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert Schuster Germany 28 653 644 623 530 328 59 2.0k
Ikuyo Kusaka Japan 22 560 0.9× 223 0.3× 313 0.5× 394 0.7× 108 0.3× 52 1.4k
Tatsumi Moriya Japan 27 708 1.1× 332 0.5× 204 0.3× 352 0.7× 346 1.1× 94 2.3k
Hisashi Makino Japan 27 417 0.6× 509 0.8× 435 0.7× 634 1.2× 154 0.5× 63 1.9k
Milita Crisby Sweden 26 260 0.4× 504 0.8× 1.1k 1.8× 580 1.1× 85 0.3× 42 2.4k
Seibu Mochizuki Japan 27 643 1.0× 1.6k 2.4× 691 1.1× 783 1.5× 177 0.5× 136 3.0k
Winfried Maerz Germany 22 438 0.7× 704 1.1× 519 0.8× 387 0.7× 136 0.4× 45 1.9k
Mojgan Yazdanpanah Netherlands 17 369 0.6× 281 0.4× 673 1.1× 205 0.4× 197 0.6× 35 1.4k
Kazuoki Kondo Japan 27 1.1k 1.7× 433 0.7× 503 0.8× 691 1.3× 87 0.3× 120 2.6k
Ewa Karwatowska‐Prokopczuk United States 27 710 1.1× 1.7k 2.7× 1.3k 2.0× 802 1.5× 93 0.3× 62 3.3k
Katariina Kainulainen Finland 24 249 0.4× 815 1.3× 152 0.2× 607 1.1× 1.0k 3.1× 37 2.5k

Countries citing papers authored by Herbert Schuster

Since Specialization
Citations

This map shows the geographic impact of Herbert Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Schuster more than expected).

Fields of papers citing papers by Herbert Schuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Schuster. The network helps show where Herbert Schuster may publish in the future.

Co-authorship network of co-authors of Herbert Schuster

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Schuster. A scholar is included among the top collaborators of Herbert Schuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Schuster. Herbert Schuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schuster, Herbert. (2007). The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk. Expert Review of Cardiovascular Therapy. 5(2). 177–193. 26 indexed citations
2.
Schuster, Herbert, Björn Fagerberg, S. Edwards, et al.. (2007). Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis. 197(1). 355–362. 27 indexed citations
3.
Schuster, Herbert. (2006). Does rosuvastatin improve lipid levels in patients with the metabolic syndrome more effectively than atorvastatin?. Nature Clinical Practice Cardiovascular Medicine. 3(2). 74–75. 2 indexed citations
4.
Schuster, Herbert, Philip J. Barter, Steen Stender, et al.. (2004). Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study. American Heart Journal. 147(4). 705–712. 134 indexed citations
5.
Schuster, Herbert & Jonathan C. Fox. (2004). Investigating cardiovascular risk reduction – the Rosuvastatin GALAXY Programme™. Expert Opinion on Pharmacotherapy. 5(5). 1187–1200. 35 indexed citations
6.
Schuster, Herbert. (2003). Effects of switching to rosuvastatain from atorvastatin or other statins on achievement of international low-density lipoprotein cholesterol goals: MERCURY I trial. Journal of the American College of Cardiology. 41(6). 227–228. 3 indexed citations
7.
8.
Schuster, Herbert. (2003). Managing the high-risk patient: therapeutic approaches in 2002. Atherosclerosis Supplements. 4(1). 15–20. 2 indexed citations
9.
Vergopoulos, Athanasios, Hans Knoblauch, & Herbert Schuster. (2002). DNA Testing for Familial Hypercholesterolemia. PubMed. 2(4). 253–262. 10 indexed citations
10.
Knoblauch, Hans, Herbert Schuster, Friedrich C. Luft, & J. Reich. (2000). A pathway model of lipid metabolism to predict the effect of genetic variability on lipid levels. Journal of Molecular Medicine. 78(9). 507–515. 25 indexed citations
11.
Busjahn, Andreas, Hans Knoblauch, Hans‐Dieter Faulhaber, et al.. (2000). A region on chromosome 3 is linked to dizygotic twinning. Nature Genetics. 26(4). 398–399. 25 indexed citations
12.
Boeckel, Thomas P. Van, Athanasios Vergopoulos, Sylvia Bähring, et al.. (1999). A new mutation in the elastin gene causing supravalvular aortic stenosis. The American Journal of Cardiology. 83(7). 1141–1143. 15 indexed citations
13.
Pfeufer, Arne, Andreas Busjahn, Athanasios Vergopoulos, et al.. (1998). Chymase gene locus is not associated with myocardial infarction and is not linked to heart size or blood pressure. The American Journal of Cardiology. 82(8). 979–981. 7 indexed citations
14.
Schuster, Herbert, Okan Toka, Hakan R. Toka, et al.. (1998). A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly. Kidney International. 53(1). 167–172. 21 indexed citations
15.
Schuster, Herbert, Thomas F. Wienker, Sylvia Bähring, et al.. (1996). Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nature Genetics. 13(1). 98–100. 95 indexed citations
16.
17.
Undt, Gerhard, K Hollmann, Herbert Schuster, & Michael Rasse. (1996). Pedicled Calvarial Bone Flap for Reconstruction of the Anterior Skull Base Following Tumor Resection. Plastic & Reconstructive Surgery. 98(4). 730–734. 10 indexed citations
18.
Schuster, Herbert, et al.. (1995). An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. The American Journal of Cardiology. 76(8). 601–603. 36 indexed citations
19.
Xu, Chun‐Fang, Philippa J. Talmud, Herbert Schuster, et al.. (1994). Association between genetic variation at the APO AI‐CIII‐AIV gene cluster and familial combined hyperlipidaemia. Clinical Genetics. 46(6). 385–397. 67 indexed citations
20.
Feussner, Giso & Herbert Schuster. (1992). Screening for the apolipoprotein B‐100 arginine3500→ glutamine mutation in patients with type III hyperlipoproteinemia. Clinical Genetics. 42(6). 302–305. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ikuyo Kusaka Breakdown of academic impact, for papers by Tatsumi Moriya Breakdown of academic impact, for papers by Hisashi Makino Breakdown of academic impact, for papers by Milita Crisby Breakdown of academic impact, for papers by Seibu Mochizuki Breakdown of academic impact, for papers by Winfried Maerz Breakdown of academic impact, for papers by Mojgan Yazdanpanah Breakdown of academic impact, for papers by Kazuoki Kondo Breakdown of academic impact, for papers by Ewa Karwatowska‐Prokopczuk Breakdown of academic impact, for papers by Katariina Kainulainen
Rankless by CCL
2026